NeoGenomics, Inc. Deferred Tax Liabilities, Gross
NeoGenomics, Inc. (NEO) had Deferred Tax Liabilities, Gross of $89.94 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-17
- 2025-12-31: Deferred Tax Liabilities, Gross $89.94M.
- 2024-12-31: Deferred Tax Liabilities, Gross $103.11M.
- 2023-12-31: Deferred Tax Liabilities, Gross $118.37M.
- 2022-12-31: Deferred Tax Liabilities, Gross $129.55M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $89.94M 10-K · filed 2026-02-17 |
| 2024-12-31 | $103.11M 10-K · filed 2026-02-17 |
| 2023-12-31 | $118.37M 10-K · filed 2025-02-18 |
| 2022-12-31 | $129.55M 10-K · filed 2024-02-20 |
| 2021-12-31 | $143.08M 10-K · filed 2023-02-24 |
| 2020-12-31 | $62.99M 10-K · filed 2022-02-25 |
| 2019-12-31 | $46.56M 10-K · filed 2021-02-25 |
| 2018-12-31 | $44.80M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |